EUCOPE News by Category — News

Filtered by Category: News

News - April 16, 2019

France Biotech HealthTech Investor Day – 24/25 June, Paris

France Biotech, with the help of the European health innovation ecosystem, is organising a HealthTech Investor Day in Paris on 24/25 June 2019. This European business event aims to connect leading investors (European, American and Asian), pharmaceuticals companies and C-level executives from European innovative companies… read more

News - April 1, 2019

EC Gets Ready for a No Deal Brexit

In the event the United Kingdom leaves the EU without a deal, access to medicines may be affected and to alleviate any doubts, the EMA has published a questions & answers document on the preparatory work to prevent medicine shortages. If at any point in… read more

News - February 28, 2019

Gene & Cell Therapy: From Discovery to Access – Event

EUCOPE, together with SME Connect and SME Europe is organising an event at the European Parliament on the opportunities and challenges of gene and cell therapies – 05 March. Entitled ‘From Discovery to Access: How can we ensure Europe is at the forefront of innovation… read more

News - February 13, 2019

Germany Agrees on New Pharmaceutical Bill

On 30 January, the German government has agreed on a draft Act for more safety in the supply of pharmaceuticals (“GSAV”). Although the wording of the original bill has been amended since it was released by the Ministry of Health last year, it still contains… read more

News - January 24, 2019

EURORDIS Multi-stakeholder Symposium, 13-14 February, Brussels

EURORDIS, the non-profit alliance representing rare diseases patient organisations will organise its 3rd Multi-Stakeholder Symposium on Improving Patients’ Access to Rare Disease Therapies on 13-14 February 2019 in Brussels, Belgium. The event will bring together stakeholders from various backgrounds to discuss sustainable solutions to improve… read more

News - January 10, 2019

EMA Public Consultation on Patient Registries

The European Medicines Agency (EMA) has released for public consultation a discussion paper on the use of patient disease registries for regulatory purposes – methodological and operational considerations. Patient registries are organised systems that use observational methods to collect uniform data on a population defined… read more